e-learning
resources
Vienna 2009
Tuesday, 15.09.2009
Sarcoidosis and profiles of other diffuse parenchymal lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
αVβ6 integrin expression in interstitial lung diseases
S. Wilkinson, J. Porte, G. Jenkins (Nottingham, United Kingdom)
Source:
Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease
Session:
Sarcoidosis and profiles of other diffuse parenchymal lung disease
Session type:
E-Communication Session
Number:
3136
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Wilkinson, J. Porte, G. Jenkins (Nottingham, United Kingdom). αVβ6 integrin expression in interstitial lung diseases. Eur Respir J 2009; 34: Suppl. 53, 3136
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Pulmonary sarcoidosis
Related content which might interest you:
Increased cytokeratin-19 expression in fibrotic interstitial lung disease
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010
SMAD2 mRNA expression is upregulated in fibrosing interstitial lung diseases (ILDs)
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
The role of macrophages in interstitial lung diseases
Source: Eur Respir Rev, 26 (145) 170009; 10.1183/16000617.0009-2017
Year: 2017
The role of CX3CL1 and ADAM17 in pathogenesis of diffuse parenchymal lung diseases
Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia
Year: 2021
Expression of TGF-β1 and TGFβ receptors in lung tissue of patients with idiopathic interstitial pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 312s
Year: 2002
Looking for airways periostin in patients with interstitial lung diseases.
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Year: 2018
Morphomolecular motifs of pulmonary neoangiogenesis in interstitial lung diseases
Source: Eur Respir J, 55 (3) 1900933; 10.1183/13993003.00933-2019
Year: 2020
a
E
b7
integrin (CD103-
b7
) expression in bronchoalveolar T lymphocytes in interstitial lung diseases
Source: Eur Respir J 2007; 30: Suppl. 51, 576s
Year: 2007
Chemokine receptors in a regulation of interstitial lung fibrosis and inflammation
Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease
Year: 2008
Increased CCL18 production in interstitial lung diseases is associated with fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 38s
Year: 2004
The role of expression of TLR 4 in bleomycin-induced pulmonary fibrosis in mice
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
B cell activating factor belonging to the TNF family might be a useful biomarker in interstitial lung diseases associated with connective tissue diseases
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
The pronounced high expression of discoidin domain receptor 2 in human interstitial lung diseases
Source: ERJ Open Res, 4 (1) 00138-2016; 10.1183/23120541.00138-2016
Year: 2018
Increased intraalveolar level of soluble endothelial protein C receptor in patients with interstitial lung disease
Source: Eur Respir J 2004; 24: Suppl. 48, 319s
Year: 2004
Differential expression of stromal cell derived factor-1/CXC chemokine receptor 4 (SDF-1/CXCL12 – CXCR4) biological axis between idiopathic pulmonary fibrosis and interstitial pneumonia associated with collagen vascular disease: a bronchoalveolar la
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008
PAR-2 agonists induce TGF-beta and EMT leading to lung fibrosis
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013
High ICAM-1 gene expression in pulmonary fibroblasts of COPD patients: a reflection of an enhanced immunological function
Source: Eur Respir J 2006; 28: 113-122
Year: 2006
Differential gene expression of lung fibroblasts derived from UIP and NSIP patterns of interstitial lung disease
Source: Eur Respir J 2002; 20: Suppl. 38, 478s
Year: 2002
KL-6, SP-D and MMP-7 as serum biomarkers for early detection of interstitial lung diseases
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Role of IL23 in the development of fibrotic interstitial lung disease
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept